Our aim was to assess the impact of the association between elevated oestradiol (E 2 ) and low testosterone (T) levels on erectile dysfunction (ED) severity. A total of 614 male patients with ED and a normal or low T level in association with normal or elevated E 2 levels were enrolled. Patients underwent routine laboratory investigations in addition to measurements of total T, total E 2 , follicle-stimulating hormone (FSH), luteinizing hormone (LH) and prolactin. We compared the responses to the erectile function domain, Q3 (achieving erection) and Q4 (maintaining erection) of the International Index for Erectile Function (IIEF) score in patients with the following: normal T and E 2 levels; low T level; low T level and elevated E 2 level; and elevated E 2 level. Of the patients included, 449 (73.1%) had normal T and E 2 levels, 110 (17.9%) had a low T level, 36 (5.9%) had a low T level and an elevated E 2 level, and 19 (3.1%) had an elevated E 2 level. Increased ED severity was significantly associated with low T levels, elevated E 2 levels, and both a low T level and an elevated E 2 level. Additionally, the mean values of the EF-domain, Q3 and Q4 were significantly lower in patients with both a low T level and an elevated E 2 level compared to patients with any condition alone.
INTRODUCTION
A diminution in testicular function with a consequence of testosterone (T) depletion is a common occurrence in older men.
1,2 The multi-factorial mechanisms of this phenomenon, which involve the hypothalamic-pituitary-testicular axis, have been reported. 3 Several studies have demonstrated that T has substantial effects on cavernosal tissues and that T deficiency impairs the anatomic and physiological substrates of erectile capacity that could be partly reversed upon androgen replacement. 4, 5 Oestradiol (E 2 ) possesses an opposing functional role of T; therefore, a decline in the T level will affect its physiological balance with E 2 in men. 6 As a consequence, a high E 2 level, which has a strong gonadotropin suppressive effect, may lead to secondary hypogonadism in the ageing male. 7 Despite the concomitant elevation of E 2 in hypogonadal men, the information available on the physiological role of E 2 in erectile function is insufficient to correlate the aetiology of erectile dysfunction (ED) to a high E 2 level. 8 The likelihood of E 2 affecting the T balance and the independent effect of E 2 on erectile function have not been well evaluated. 9 Furthermore, although the association between ED severity and the prospective decrease in testosterone has been investigated, 10 the impact of an elevated E 2 level on ED severity has not been well addressed. The current study was designed to assess the impact of an association between an elevated E 2 level and a low T level on ED severity.
MATERIALS AND METHODS

Research design
This was a prospective office-based study. From January 2009 to December 2010, 614 male patients with a clinical diagnosis of ED associated with normal or low T and/or elevated E 2 levels who visited our andrology clinic were enrolled in this study.
ED assessment
Patients were screened for ED using the International Index for Erectile Function (IIEF). 11 The erectile function domain consists of questions 1-5 and question 15 for assessing the global erectile function. These questions were used to measure items regarding ability to obtain an erection, the hardness of the erection, penetration ability, ability to maintain an erection, difficulty maintaining an erection until the end of intercourse and erection confidence. In the current study, we did not investigate the internal consistency of the IIEF scale or subscales; however, previous studies in different languages have demonstrated that the intraclass correlation coefficients (test-retest reproducibility) of the IIEF scale and subscales are significantly high. Cronbach's alpha coefficient has also indicated a high internal consistency. 12, 13 Scoring the IIEF domain of erectile function allowed the classification of each patient as having no (26) (27) (28) (29) (30) , mild (17) (18) (19) (20) (21) (22) (23) (24) (25) , moderate (11) (12) (13) (14) (15) (16) or severe (0-10) ED. At the same visits during which they were assessed for ED, all patients were also interviewed to gather their sociodemographic characteristics and relevant medical history. We compared the responses to the erectile function domain, Q3 (achieving erection), Q4 (maintaining erection) and ED duration in patients with (i) normal T and E 2 levels, (i) a low T level with a normal E 2 level, (iii) a low T level and an elevated E 2 level and (iv) an elevated E 2 level with a normal T level. Patients gave informed consent to be included in the study. The study was approved by the Institutional Review Board.
Laboratory assessment
Patients underwent routine laboratory investigations in addition to evaluations of total T, total E 2 , follicle-stimulating hormone (FSH), luteinizing hormone (LH) and prolactin.
Total T, total E 2 , FSH, LH and prolactin were assessed using electrochemiluminescence immunoassays according to the manufacturer's instructions (Elecsys Systems 20/10; Roche Diagnostics Corporation, Indianapolis, IN, USA). The target values and ranges were determined and obtained using the Elecsys assay reagents and analysers available at the time. The measurement range (0.025-15.0 ng ml 21 or 0.087-52.0 nmol l 21 ) was defined by the limit of detection and the maximum of the master curve. The interassay coefficient of variation for total T at concentrations of 24-700 ng dl 21 (0.83-24.31 nmol l
21
) was 7.4%-1.7%. Elecsys PreciControl Universal 1 and 2 were used for quality control; these reagents contain lyophilised control serum based on human serum in two concentration ranges. The controls were used to monitor the accuracy and precision of the Elecsys immunoassays. 
Definitions
Data analysis
The data were analysed using the Statistical Package for the Social Sciences (SPSS.14.0) software programme (SPSS, Inc., Chicago, IL, USA). The chi-square test was used to compare categorical variables, including sociodemographics, medical comorbidities, ED severity and ED duration according to the four categories of T and E 2 patterns (Tables 1 and 2 ). An unpaired t-test and oneway ANOVA were used to compare the mean values of the erectile function domain, Q3 and Q4 according to the four categories of T and E 2 patterns (Tables 2 and 3) .
RESULTS
Sociodemographics and characteristics of the study population A total of 614 male patients were included in this study. Of the patients, 449 (73.1%) had normal T and E 2 levels, 110 (17.9%) had a low T level, 36 (5.9%) had a low T level and an elevated E 2 level and 19 (3.1%) had an elevated E 2 level. The mean age and standard deviation of the study sample was 56.6611.4 years, and 36.6% were less than 50 years of age. Additionally, 78.7% were overweight or obese, and 29.5% were current or ex-smokers. The majority of patients (78.8%) had one or more risk factors or medical comorbidities (diabetes, hypertension, dyslipidaemia, ischaemic heart disease) ( Table 1) . Elevated estradiol and low testosterone in ED patients AI El-Sakka 493
Risk factors in the study population A normal hormonal pattern was identified in 87.1% (196/225) of patients less than 50 years of age and 86.2% (112/130) of patients with no risk factors. Patients with a normal hormonal pattern had a significantly lower BMI and were less likely to smoke in comparison to patients with a low T level and high E 2 level (P,0.05 for each) ( Table 1) . Age, obesity, smoking and medical comorbidities did not significantly differ among patients with low T alone and patients with both a low T level and an elevated E 2 level (P.0.05 for each) ( Table 1) .
Hormonal pattern and ED Increased ED severity was significantly associated with a low T level, an elevated E 2 level, and both a low T level and an elevated E 2 level (P,0.05 for each) ( Tables 2 and 3) . No significant association was observed between hormonal abnormalities and ED duration (P.0.05 for each) ( Table 2 ). The mean values of the EF-domain, Q3 and Q4 were significantly lower in patients with both a low T level and an elevated E 2 level compared to patients with any of the conditions alone (P,0.05 for each) ( Table 2 ). Patients with low T only had significantly lower mean values of the EF-domain, Q3 and Q4 compared to patients with a normal hormonal pattern (P,0.05 for each) ( Table 2) . No significant differences in the mean values of the EF-domain, Q3 and Q4 were observed between patients with low T and patients with elevated E 2 levels (P.0.05 for each) ( Table 2) . ED severity was not significantly associated with high level of FSH, LH, prolactin or the lipid profile in the study population (P.0.05 for each) ( Table 3) . 
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DISCUSSION
In this study, we assessed the impact of low T level and elevated E 2 level individually and together on ED severity. We demonstrated that both low T level and elevated E 2 level had a negative impact on erectile function and were associated with increased ED severity. No significant associations between hormonal abnormalities and ED duration were observed. The Massachusetts Male Aging Study reported a prevalence of 20% for hypogonadism in men older than 55 years of age when total T levels were lower than normal for young healthy subjects. 14 In the current study, we found that 23.8% of patients had low T only or low T in addition to elevated E 2 . The mechanisms behind the ageing-associated decrease in androgen level and the decrease patients with ED have not been fully elucidated. In a previous study, we demonstrated the yearly pattern of T depletion in patients with ED. 10 Furthermore, the possibility of decreased testicular function in older men has been reported to result from several factors, including a disturbance in the hypothalamic-pituitary-testicular axis. 3 Oestrogens are generally considered as female hormones. However, data obtained from more recent studies have noted the role of oestrogens in male reproduction, which in the past, was a concept confined only to female reproduction. 15 The pathophysiological consequences of elevated E 2 in males have recently gained interest. Oestrogen has been reported to have a significantly negative effect on sexual behaviour and ultimately results in decreased intracavernosal pressure and nitric oxide-mediated cavernosal smooth muscle relaxation. 16, 17 In addition, the action of E 2 through a non-genomic mechanism has been reported in which E 2 can modulate the cell surface and influence ionic channels as a part of the tissue response. 18 Although the elevated E 2 levels in ageing males may act as a risk factor for ED, 9 the causeeffect relationship is still unknown.
19
A recent large population-based study showed that total and free T, but not E 2 or dihydrotestosterone (DHT), was associated with overall sexual function in middle-aged and older men. E 2 was the only hormone associated with sexual function-related distress, such that higher levels were related to greater distress. 20 Although several interesting studies have elucidated the role of E 2 in male reproduction, data on the peripheral levels of sex steroids are lacking. Huhtaniemi et al. 21 reported that increased oestrogen activity rather than decreased androgen activity is associated with longer androgen receptor CAG repeats. Furthermore, Saltiki et al. 22 investigated the effect of oestrogen levels on endothelial function in males and concluded that endogenous oestrogen levels were associated with flow-mediated dilatation, independent of age and lipid levels, showing a protective effect in middle-aged male subjects.
Although androgen and E 2 are physiological antagonists in many organs, the impact of E 2 on the T balance is unclear; therefore, ED in the elderly may result from a pathophysiological E 2 -T imbalance. 23 This hormonal imbalance in the elderly can be attributed, at least in part, to modifiable para-aging phenomena. In the present study, there was a significant increase in BMI in patients with both low T and high E 2 . Age, obesity, smoking and medical co-morbidities were not significantly different among patients with low T alone and patients with both a low T level and an elevated E 2 level. This finding is consistent with previous studies showing a complex relationship between ED and hormonal imbalance in obese patients. Furthermore, associations of obesity and its negative correlation with leptin level and androgen insensitivity have been reported. 9, 24, 25 With increasing BMI, waist circumference and per cent body fat, another study showed that total and free testosterone and sex hormone-binding globulin concentrations decreased, while total and free E 2 increased. The magnitudes of the changes of these hormones were similar, with a one-quartile increase in each body fat measure. 26 In addition to the hormonal imbalance that can occur with ageing, type 2 diabetes, obesity, hypercholesterolaemia and cardiovascular disease, some of these clinical states are known risk factors for ED. A more recent study demonstrated that the calculated free E 2 concentration in men with a subnormal free T concentration was lower than that in men with a normal free T concentration. Directly measured free E 2 concentrations were also lower in men with subnormal free testosterone concentrations. 27 The suppression of the hypothalamic-pituitary-gonadal axis in patients with subnormal free T concentrations and type 2 diabetes has not been associated with increased E 2 concentrations. 27 In the current study, low T and/or elevated E 2 levels were associated with increased ED severity. A low T level caused the primary effect; however, the existence of a concomitantly elevated E 2 level increased the severity of ED. A previous study has demonstrated that an E 2 -T imbalance and relative elevation of E 2 may play a role in the causation and perpetuation of ED. Testosterone supplements improve sexual function in patients with hypogonadism. However, the value of T supplementation, which may be aromatised to E 2 in men with possible hyperoestrogenism, is questionable. 28 A more recent review of the literature demonstrated that the current evidence does not support a role of naturally occurring oestrogen elevations in testosterone deficiency or the treatment of elevated oestrogens during testosterone therapy. 29 Empirical clomiphene citrate (anti-estrogen) was shown to improve sexual function in a group of ED patients with hypogonadism. 30 Although the aromatase inhibitor anastrozole increased both bioavailable and total T and reduced E 2 , there was no concurrent improvement in the IIEF scores, indicating the importance of other coexistent factors. 31 Previous studies have reported the importance of the E 2 /T ratio. However, in the current study, we addressed the impacts of the absolute value of each individually and together on ED severity. Extrapolating those findings could raise several clinically relevant issues, including whether an E 2 assay may eventually find a place in the routine clinical investigation of ED. The E 2 /T ratio may be a useful diagnostic marker for hormonal abnormalities in ED patients and for hormone follow-up through appropriate therapeutic titration.
Although the Elecsys system and the electrochemiluminescence immunoassay might not currently be the state of the art for measuring steroid levels, they are capable of distinguishing eugonadal males from hypogonadal males if adult male reference ranges have been established in each individual laboratory, and they have been reported to accurately identify low T levels in men. 32 A potential methodological limitation of our study is the relatively small number of patients in some categories of hormonal abnormalities. Age, obesity, smoking and medical comorbidities did not significantly differ among patients with low T alone and patients with both a low T level and an elevated E 2 level, which suggests that they had little effect on the difference in ED severity between groups. However, the exclusive influence of those possible confounders on each category of hormonal pattern was not addressed in the present study and will be considered in future studies.
The subjects and standard instruments we used indicate that our findings are reliable and certainly signify a good base for further studies. Additional studies with a larger sample size are needed to investigate how much both low T and high E 2 affect the pathogenesis of ED, particularly the vascular, cavernosal smooth muscle and neuronal mechanisms of erection. Future research should also investigate other unclear issues, including how low T and high E 2 influence each other Elevated estradiol and low testosterone in ED patients AI El-Sakka 495
and whether the normal male ageing process is responsible for the pathophysiology of ED in association with both hormonal abnormalities. Future studies should also examine the presence of concurrent organic conditions and medical comorbidities that predispose individuals to similar hormonal derangements that may ultimately affect successful management outcomes.
Conclusion
Low T and elevated E 2 levels are associated with increase ED severity when present individually or concomitantly. A low T level demonstrated the principal effect; however, the existence of a concomitantly elevated E 2 level increased the severity of ED in patients with a low T level.
